Synthesis of Chiral 1-[ω-(4-Chlorophenoxy)alkyl]-4-methylpiperidines and Their Biological Evaluation at σ1, σ2, and Sterol Δ8−Δ7 Isomerase Sites
- 25 April 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (11) , 2117-2124
Abstract
Sumitomo's patented σ ligand 1-[3-(4-chlorophenoxy)propyl]-4-methylpiperidine (15), which has been claimed as agent for CNS disorders and neuropathies, and its lower homologue 12 were prepared along with related chiral (4-chlorophenoxy)alkylpiperidines. They were tested at σ1, σ2, and sterol Δ8−Δ7 isomerase (SI) sites by in vitro radioligand binding assays, to evaluate the influence of a chiral center in the alkyl chain on the selective σ1 binding relative to other σ family sites. Generally high σ1-site affinities were found, so that the chirality introduced by a methyl substitution resulted in slight differences. Nevertheless, the shorter oxyethylenic chain was beneficial to increase σ1 selectivity. However, the (−)-(S)-4-methyl-1-[2-(4-chlorophenoxy)-1-methylethyl]piperidine ((−)-(S)-17) reached the highest σ1 affinity (Ki = 0.34 nM) and the best selectivity relative to the σ2 site (547-fold). Compound (−)-(S)-17 displayed also a moderate selectivity (11-fold) relative to the SI site.Keywords
This publication has 36 references indexed in Scilit:
- The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel SubunitNeuron, 2002
- The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunitiesBrain Research Reviews, 2001
- Modulation of serotonergic neurotransmission by short‐ and long‐term treatments with sigma ligandsBritish Journal of Pharmacology, 2001
- A multireceptorial binding reinvestigation on an extended class of σ ligands: N-[ω-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards σ1 and EBP sitesBioorganic & Medicinal Chemistry, 2001
- The anti-amnesic effects of sigma1 (σ1) receptor agonists confirmed by in vivo antisense strategy in the mouseBrain Research, 2001
- E-5842Drugs of the Future, 1999
- Modulation of nmda and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disordersLife Sciences, 1996
- Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labelingEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- A proposal for the classification of sigma binding sitesTrends in Pharmacological Sciences, 1992
- Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogsJournal of Medicinal Chemistry, 1987